Molecular genetic alterations in gliomatosis cerebri: What can we learn about the origin and course of the disease?

被引:20
作者
Mawrin, C [1 ]
机构
[1] Otto Von Guericke Univ, Dept Neuropathol, D-39120 Magdeburg, Germany
关键词
gliomatosis cerebri; p53; tumor infiltration; astrocytoma progression; clonality;
D O I
10.1007/s00401-005-1083-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Gliomatosis cerebri (GC) is a neuroepithelial neoplasm with extensive infiltration of large parts of the brain. Recent data showing the involvement of TP53 mutation or nuclear protein accumulation in some cases have linked the astrocytic phenotype of the tumor cells to TP53 alterations frequently found in common astrocytomas. However, the frequency of these alterations is low, and other molecular genetic changes have been only rarely identified. Those found in common high-grade astrocytomas and glioblastomas are usually missing in GC. The distribution of TP53 point mutations, as well as non-coding polymorphic markers and some cytogenetic data, support a monoclonal origin in some cases, and are at least compatible with it in most cases, while no conclusive data suggesting a polyclonal origin have been reported. This raises the question of mechanisms responsible for the enhanced infiltrative potential of the tumor cells in this disease, which have not yet been identified.
引用
收藏
页码:527 / 536
页数:10
相关论文
共 62 条
[1]   ROLE OF CD44 IN THE INVASIVENESS OF GLIOBLASTOMA-MULTIFORME AND THE NONINVASIVENESS OF MENINGIOMA - AN IMMUNOHISTOCHEMISTRY STUDY [J].
ARIZA, A ;
LOPEZ, D ;
MATE, JL ;
ISAMAT, M ;
MUSULEN, E ;
PUJOL, M ;
LEY, A ;
NAVASPALACIOS, JJ .
HUMAN PATHOLOGY, 1995, 26 (10) :1144-1147
[2]  
ARTIGAS J, 1985, CLIN NEUROPATHOL, V4, P135
[3]   HYALURONATE BINDING AND CD44 EXPRESSION IN HUMAN GLIOBLASTOMA CELLS AND ASTROCYTES [J].
ASHER, R ;
BIGNAMI, A .
EXPERIMENTAL CELL RESEARCH, 1992, 203 (01) :80-90
[4]  
BALKO MG, 1992, HUM PATHOL, V23, P706
[5]  
Bange J, 2002, CANCER RES, V62, P840
[6]   Possible efficacy of temozolomide in a patient with gliomatosis cerebri [J].
Benjelloun, A ;
Delavelle, J ;
Lazeyras, F ;
Dietrich, PY .
NEUROLOGY, 2001, 57 (10) :1932-1933
[7]   Fibroblast growth factor receptors: lessons from the genes [J].
Burke, D ;
Wilkes, D ;
Blundell, TL ;
Malcolm, S .
TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (02) :59-62
[8]   Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].
Cairncross, JG ;
Ueki, K ;
Zlatescu, MC ;
Lisle, DK ;
Finkelstein, DM ;
Hammond, RR ;
Silver, JS ;
Stark, PC ;
Macdonald, DR ;
Ino, Y ;
Ramsay, DA ;
Louis, DN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479
[9]   Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer [J].
Catzavelos, C ;
Bhatacharya, N ;
Ung, YC ;
Wilson, JA ;
Roncari, L ;
Sandhu, C ;
Shaw, P ;
Yeger, H ;
MoravaProtzner, I ;
Kapusta, L ;
Franssen, E ;
Pritchard, KI ;
Slingerland, JM .
NATURE MEDICINE, 1997, 3 (02) :227-230
[10]  
CAVENEE WK, 2000, PATHOLOGY GENETICS T, P9